Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Momenta Pharmaceuticals
Biotech
Alchemab CEO resigns citing 'personal reasons'—Chutes & Ladders
Alchemab CEO suddenly resigns. Infant biotech Civeta builds out scientific leadership. Rajangam jumps from Nkarta to Senti Bio.
Max Bayer
May 27, 2022 9:30am
J&J, free from rival bidders, made Momenta wait on $6.5B deal
Sep 3, 2020 9:00am
J&J inks $6.5B Momenta buyout to bag autoimmune drug
Aug 19, 2020 8:25am
Chutes & Ladders—Pfizer's Ian Read hands reins to COO Bourla
Oct 5, 2018 10:00am
Momenta calls time on biosimilar R&D
Oct 2, 2018 8:56am
Christoph Westphal back on the horse with immunotherapy startup
May 3, 2018 11:05am
